
Sulfonamides, Platelets, Thrombosis and Haemostasis, Heparin, Pipecolic Acids, Anticoagulants, Humans, Anticoagulants/adverse effects; Arginine/analogs & derivatives; Heparin/adverse effects; Humans; Pipecolic Acids/therapeutic use; Retrospective Studies; Sulfonamides/adverse effects; Thrombocytopenia/chemically induced; Thrombocytopenia/drug therapy; anticoagulation; argatroban; argatroban monitoring; heparin-induced thrombocytopenia; plasmatic argatroban concentration, Arginine, Thrombocytopenia, Retrospective Studies
Sulfonamides, Platelets, Thrombosis and Haemostasis, Heparin, Pipecolic Acids, Anticoagulants, Humans, Anticoagulants/adverse effects; Arginine/analogs & derivatives; Heparin/adverse effects; Humans; Pipecolic Acids/therapeutic use; Retrospective Studies; Sulfonamides/adverse effects; Thrombocytopenia/chemically induced; Thrombocytopenia/drug therapy; anticoagulation; argatroban; argatroban monitoring; heparin-induced thrombocytopenia; plasmatic argatroban concentration, Arginine, Thrombocytopenia, Retrospective Studies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 13 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
